You know when you're standing in a room with stroke neurologist Professor Werner Hacke; his presence is commanding; his voice booming, and his cheeks are ruddy. He is a humble man, who pulls no punches and has a direct gaze that never waivers, he is revered as a colleague and among these same colleagues valued as a friend. A well-known name in neurology, and a global leader in stroke, Professor Hacke will this October, take on the role as President of the World Stroke Organization.
The first Senior Professor of Neurology at the University of Heidelberg in Germany, Professor Hacke's non-linear progression into stroke research, via a master's degree in psychology, and then clinical neurology began straight out of high school . . . when I finished school and my notes were not good enough to get into medical school, I thought ''I will take psychology''. And, in psychology, I came close to the brain, and when I finally made it to medical school, the brain was always in the centre of my interests.
. . . at one point in time during my training, I had to go to the intensive care unit, I was confronted with patients suffering from most severe strokes and then all of a sudden, I realised ''That is what I want to do, the active way of doing stroke medicine.'' Throughout his career, Professor Hacke has significantly challenged the horizon of stroke treatment, warmly attributing the trajectory of his work to fellow researcher professor Hermann Zeumer '. . . he was a neurologist and neuroradiologist, he trained me in neuroradiology, and I assisted with the first intraarterial procedures that have ever been done in stroke patients, and that set the direction for the rest of my scientific career'.
Along with Professor Zeumer, Professor Hacke also fondly lists Professor Klaus Poeck, Chair of Neurology at the Medical School of the Technical University of Aachen, Germany at the time of his training, among his most profound mentors.
Despite the myriad of professional successes and very much in line with many stroke colleagues of his generation, Professor Hacke's important work in clinical trials has brought persistent setbacks; he recalls There were many lows [in my career], and the lows were always associated with negative clinical trials . . . I don't think that people really have an idea of how much work you put into the preparation and the execution of clinical trials, and you are sitting there, and the statistician opens his book and tells you, with no emotion on his face, that you are negative again.
In both research and medicine, a globally applicable conundrum is the constant conflict between personal and professional life; however, Professor Hacke is a proud family man, and has clearly always viewed family to be an integral facet to a positive career.
. . . it was never a problem for me to stop working at seven in the evening and have no work at all, stop working on Friday evening if I am not on call, and never work at home. So, I had a very strict balance between professional and home life . . . I think that coming back into the safe harbour of my family was possibly very important for my career.
Professor Hacke's illustrious research career has been defined by a number of key international collaborations, most notably the European Cooperative Acute Stroke Collaboration. Alongside Markku Kaste from Finland and Cesare Fieschi from Italy, Professor Hacke was part of a steering committee for a clinical trial, a group which 'worked so well that we used that for future trials, and it became kind of the grounding stone for the European Stroke Initiative, and later the European Stroke Organisation'. This eventually spawned further collaborations both within Europe and on a global scale, extending to Australia and parts of the United States.
Professor Hacke's stellar career has made him an ornament to the field of stroke. He has borne witness to so many crucial moments in this exciting area, and driven many of the changes with various collaborators; he has been an important mentor and guide, presenter and colleague to so many from around the world, and in his various roles on editorial boards and as an editor for Stroke, President of ESO and many more he has led the charge for new therapies, prevention and interventions. As he starts his presidency with the World Stroke Organization, we look forward to all that will come!
